Paul Shawah, EVP, strategy, Veeva Systems and Richard Staub, president, R&D solutions, IQVIA, explain how their partnership is improving efficiency and data management in clinical trials by ...

Two-thirds of data managers and clinical research associates (CRAs) report that inefficiencies in manual data reconciliation, ...

MILWAUKEE, WI, November 19, 2024 (EZ Newswire) -- As biopharmaceutical sponsors face increasing challenges in securing investigative sites for their clinical trials, the ability to reduce ...

In the early 2000s, Paul Harris, a research informatics faculty member and bioengineer at Vanderbilt University Medical Center, noticed a pressing problem. While working with research teams, he found ...

Today, Revvity, Inc. announced that its software and informatics division, Revvity Signals, is unveiling the Signals Clinical TM solution, a software-as-a-service (SaaS), end-to-end clinical data ...

A recent influx of digital technology has unlocked tremendous potential for clinical trials. For an industry that has traditionally relied on patients’ paper intake forms and manual data entry into ...

BOSTON--(BUSINESS WIRE)--eClinical Solutions, a global provider of digital clinical software and services, today announced that the company will be presenting at an impressive line-up of global ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. With more than a third of hospitals experiencing negative operating margins, healthcare ...

Global partnerships to help customers improve clinical and commercial efficiency and effectiveness IQVIA (NYSE: IQV) and Veeva Systems (NYSE: VEEV) today announced global clinical and commercial ...

As cycle time becomes the new currency of drug development, life sciences R&D leaders are looking to expedite adoption of AI and risk management for greater efficiency across the clinical trial ...

RESEARCH TRIANGLE PARK, N.C. and PLEASANTON, Calif., Aug. 18, 2025 /PRNewswire/ -- IQVIA (NYSE: IQV) and Veeva Systems (NYSE: VEEV) today announced global clinical and commercial partnerships and the ...